Skip to main content
Top
Published in: Hereditary Cancer in Clinical Practice 1/2012

Open Access 01-12-2012 | Research

Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations

Authors: Katarina Bartuma, Mef Nilbert, Christina Carlsson

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2012

Login to get access

Abstract

Background

A growing number of individuals are diagnosed with hereditary cancer. Though increased levels of anxiety and depression have been demonstrated around the time of genetic counselling, most individuals handle life at increased risk well. Data have, however, been collected on individual basis, which led us to focus on family perspectives of hereditary cancer.

Methods

Lynch syndrome represents a major type of hereditary colorectal and gynaecological cancer. We preformed open-ended interviews with 27 informants from 9 Lynch syndrome families. Inductive content analysis revealed three major themes: transition to a risk family, patterns of communication and influence on family relations and individual roles.

Results

Family members described how learning about Lynch syndrome shifted focus from daily issues to concerns about cancer. Changes in communication related to difficulties in talking to children about heredity and informing new family members and distant relatives about an increased risk of cancer. Influence on relations was exemplified by family members taking on different roles, e.g. females often being responsible for coordinating information about heredity and providing support. Families in which members had experienced cancer at young age typically informed children soon after learning about heredity and at young age, whereas families with experience of cancer at higher age postponed information and thereby also genetic counselling.

Conclusions

Three major family perspectives are described in Lynch syndrome families; becoming a risk family, patterns of communication and influence on family relations. Since these issues are central, our findings suggests that such family perspectives should be considered during genetic counselling in order to contribute to information spread, help family members cope with the increased risk, and motivate family members at risk to undergo surveillance.
Literature
1.
go back to reference de la Chapelle A: The incidence of Lynch syndrome. Fam Cancer 2005, 4: 233–237. 10.1007/s10689-004-5811-3CrossRefPubMed de la Chapelle A: The incidence of Lynch syndrome. Fam Cancer 2005, 4: 233–237. 10.1007/s10689-004-5811-3CrossRefPubMed
2.
go back to reference Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009, 137: 1621–1627. 10.1053/j.gastro.2009.07.039CrossRefPubMedPubMedCentral Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009, 137: 1621–1627. 10.1053/j.gastro.2009.07.039CrossRefPubMedPubMedCentral
3.
go back to reference Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009, 75: 141–149. 10.1111/j.1399-0004.2008.01125.xCrossRefPubMed Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009, 75: 141–149. 10.1111/j.1399-0004.2008.01125.xCrossRefPubMed
4.
go back to reference Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP: Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009, 27: 4793–4797. 10.1200/JCO.2009.23.7784CrossRefPubMed Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP: Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009, 27: 4793–4797. 10.1200/JCO.2009.23.7784CrossRefPubMed
5.
go back to reference Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 2008, 74: 233–242. 10.1111/j.1399-0004.2008.01035.xCrossRefPubMed Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 2008, 74: 233–242. 10.1111/j.1399-0004.2008.01035.xCrossRefPubMed
6.
go back to reference Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296: 1507–1517. 10.1001/jama.296.12.1507CrossRefPubMed Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296: 1507–1517. 10.1001/jama.296.12.1507CrossRefPubMed
7.
go back to reference Vendel Petersen Helle DK, Bendahl Pär-Ola, Wong Jiahui, Carlsson Christina, Bernstein Inge, Esplen Mary Jane, Nilbert Mef: Validation of a Self-Concept Scale for Hereditary Nonpolyposis Colorectal Cancer in Different Nationalities. , ; 2010. Vendel Petersen Helle DK, Bendahl Pär-Ola, Wong Jiahui, Carlsson Christina, Bernstein Inge, Esplen Mary Jane, Nilbert Mef: Validation of a Self-Concept Scale for Hereditary Nonpolyposis Colorectal Cancer in Different Nationalities. , ; 2010.
8.
go back to reference Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER: A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003, 12: 304–313.PubMed Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER: A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003, 12: 304–313.PubMed
9.
go back to reference Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, et al.: Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008, 6: 333–338. 10.1016/j.cgh.2007.12.014CrossRefPubMedPubMedCentral Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, et al.: Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008, 6: 333–338. 10.1016/j.cgh.2007.12.014CrossRefPubMedPubMedCentral
10.
go back to reference McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, Morrison PJ: Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009, 18: 1208–1215. 10.1002/pon.1487CrossRefPubMed McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, Morrison PJ: Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009, 18: 1208–1215. 10.1002/pon.1487CrossRefPubMed
11.
go back to reference Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E: To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003, 64: 317–326. 10.1034/j.1399-0004.2003.00142.xCrossRefPubMed Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E: To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003, 64: 317–326. 10.1034/j.1399-0004.2003.00142.xCrossRefPubMed
12.
go back to reference van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A: Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007, 71: 35–42.CrossRefPubMed van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A: Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007, 71: 35–42.CrossRefPubMed
13.
go back to reference Elo S, Kyngas H: The qualitative content analysis process. J Adv Nurs 2008, 62: 107–115. 10.1111/j.1365-2648.2007.04569.xCrossRefPubMed Elo S, Kyngas H: The qualitative content analysis process. J Adv Nurs 2008, 62: 107–115. 10.1111/j.1365-2648.2007.04569.xCrossRefPubMed
14.
go back to reference Wilkinson S: Focus group research In Qualitative research : theory, method and practice. In . 2nd edition. Edited by: Silverman D. Sage Publications, London; 2004:378. Wilkinson S: Focus group research In Qualitative research : theory, method and practice. In . 2nd edition. Edited by: Silverman D. Sage Publications, London; 2004:378.
15.
go back to reference Silverman D: Interpreting qualitative data. 3rd edition. Sage, London; 2006. Silverman D: Interpreting qualitative data. 3rd edition. Sage, London; 2006.
16.
go back to reference Foster C, Watson M, Moynihan C, Ardern-jones A, Eeles R: Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility. J Health Psychol 2002, 7: 469–484. 10.1177/1359105302007004627CrossRefPubMed Foster C, Watson M, Moynihan C, Ardern-jones A, Eeles R: Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility. J Health Psychol 2002, 7: 469–484. 10.1177/1359105302007004627CrossRefPubMed
17.
go back to reference Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118: 829–834. 10.1016/S0016-5085(00)70168-5CrossRefPubMed Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118: 829–834. 10.1016/S0016-5085(00)70168-5CrossRefPubMed
18.
go back to reference Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al.: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006, 354: 261–269. 10.1056/NEJMoa052627CrossRefPubMed Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al.: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006, 354: 261–269. 10.1056/NEJMoa052627CrossRefPubMed
19.
go back to reference South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H: Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet Med 2009, 11: 812–817. 10.1097/GIM.0b013e3181b99b75CrossRefPubMed South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H: Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet Med 2009, 11: 812–817. 10.1097/GIM.0b013e3181b99b75CrossRefPubMed
20.
go back to reference Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O’Malley DM, Cohn DE: Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol 2009, 114: 486–490. 10.1016/j.ygyno.2009.05.026CrossRefPubMed Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O’Malley DM, Cohn DE: Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol 2009, 114: 486–490. 10.1016/j.ygyno.2009.05.026CrossRefPubMed
21.
go back to reference McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003, 64: 179–189. 10.1034/j.1399-0004.2003.00133.xCrossRefPubMed McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003, 64: 179–189. 10.1034/j.1399-0004.2003.00133.xCrossRefPubMed
22.
go back to reference d’Agincourt-Canning L: The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 2005, 14: 55–69. 10.1007/s10897-005-1500-0CrossRefPubMed d’Agincourt-Canning L: The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 2005, 14: 55–69. 10.1007/s10897-005-1500-0CrossRefPubMed
23.
go back to reference Mesters I, Ausems M, Eichhorn S, Vasen H: Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 2005, 4: 163–167. 10.1007/s10689-004-7992-1CrossRefPubMed Mesters I, Ausems M, Eichhorn S, Vasen H: Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 2005, 4: 163–167. 10.1007/s10689-004-7992-1CrossRefPubMed
24.
go back to reference Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A: A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Fam Cancer 2011, 10: 87–96. 10.1007/s10689-010-9385-yCrossRefPubMed Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A: A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Fam Cancer 2011, 10: 87–96. 10.1007/s10689-010-9385-yCrossRefPubMed
25.
go back to reference Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D: All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002, 107: 143–150. 10.1002/ajmg.10110CrossRefPubMed Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D: All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002, 107: 143–150. 10.1002/ajmg.10110CrossRefPubMed
26.
go back to reference van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Riedijk SR, et al.: A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology 2007, 16: 320–328. 10.1002/pon.1062CrossRefPubMed van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Riedijk SR, et al.: A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology 2007, 16: 320–328. 10.1002/pon.1062CrossRefPubMed
27.
go back to reference Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER: How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 2003, 119C: 78–86. 10.1002/ajmg.c.10010CrossRefPubMed Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER: How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 2003, 119C: 78–86. 10.1002/ajmg.c.10010CrossRefPubMed
28.
go back to reference Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA: Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology 2006, 15: 193–208. 10.1002/pon.935CrossRefPubMed Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA: Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology 2006, 15: 193–208. 10.1002/pon.935CrossRefPubMed
29.
go back to reference Berry DS, Pennebaker JW: Nonverbal and verbal emotional expression and health. Psychother Psychosom 1993, 59: 11–19. 10.1159/000288640CrossRefPubMed Berry DS, Pennebaker JW: Nonverbal and verbal emotional expression and health. Psychother Psychosom 1993, 59: 11–19. 10.1159/000288640CrossRefPubMed
30.
go back to reference Peterson SK: The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions. Health Educ Behav 2005, 32: 627–639. 10.1177/1090198105278751CrossRefPubMed Peterson SK: The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions. Health Educ Behav 2005, 32: 627–639. 10.1177/1090198105278751CrossRefPubMed
31.
go back to reference Green RM, Thomas AM: Whose gene is it? A case discussion about familial conflict over genetic testing for breast cancer. J Genet Couns 1997, 6: 245–254. 10.1023/A:1025672421311CrossRefPubMed Green RM, Thomas AM: Whose gene is it? A case discussion about familial conflict over genetic testing for breast cancer. J Genet Couns 1997, 6: 245–254. 10.1023/A:1025672421311CrossRefPubMed
Metadata
Title
Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations
Authors
Katarina Bartuma
Mef Nilbert
Christina Carlsson
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Hereditary Cancer in Clinical Practice / Issue 1/2012
Electronic ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-10-6

Other articles of this Issue 1/2012

Hereditary Cancer in Clinical Practice 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine